Jupiter Research Capital (Asia) Ltd’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$303K Sell
11,732
-4,167
-26% -$90.1K 0.03% 489
2026
Q2
$321K Buy
+15,899
New +$321K 0.04% 520

Other funds holding AMPH

Jupiter Research Capital (Asia) Ltd's AMPH Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd reduced its Amphastar Pharmaceuticals (AMPH) stake by 26% in Q3 2026, selling an estimated $90.1K and leaving 11,732 shares worth $303K. The position accounts for 0.03% of the portfolio, ranked #489.

Jupiter Research Capital (Asia) Ltd first reported a position in AMPH in Q2 2026 and has held it in 2 quarters since. The position peaked at $321K in Q2 2026. 219 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd held 11,732 shares of Amphastar Pharmaceuticals worth $303K as of Q3 2026.
  • Jupiter Research Capital (Asia) Ltd sold 4,167 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $90.1K.
  • Amphastar Pharmaceuticals made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #489 holding.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Amphastar Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Jupiter Research Capital (Asia) Ltd's Amphastar Pharmaceuticals position peaked at $321K in Q2 2026.
  • 219 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.